← Leaderboards
Kathleen Kelly
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateCellsGrowthPathway InteractionsTissuesMalignant NeoplasmsEpithelial CellsOrganoidsIn VivoPhenotypeSignal TransductionEpithelialNeoplasm MetastasisCastrationIn VitroMediatingCell LineSamplingTumorAdenocarcinomaResistanceMouse ModelProstateAndrogens
Grant awards (65)
Mechanisms of pathogenesis in patient derived organoid models of prostate cancer$352,810
ZIA · FY2024 · CA · contact PI
Biology of AR+ prostate cancer metastases and the role of the microenvironment$147,004
ZIA · FY2024 · CA · contact PI
Identifying genetic vulnerabilities in neuroendocrine prostate cancer$88,203
ZIA · FY2024 · CA · contact PI
Mechanisms of pathogenesis in patient derived organoid models of prostate cancer$1,336,035
ZIA · FY2023 · CA · contact PI
Biology of AR+ prostate cancer metastases and the role of the microenvironment$556,681
ZIA · FY2023 · CA · contact PI
Identifying genetic vulnerabilities in neuroendocrine prostate cancer$334,009
ZIA · FY2023 · CA · contact PI
Mechanisms of pathogenesis in patient derived organoid models of prostate cancer$1,401,521
ZIA · FY2022 · CA · contact PI
Biology of AR+ prostate cancer metastases and the role of the microenvironment$467,174
ZIA · FY2022 · CA · contact PI
Identifying genetic vulnerabilities in neuroendocrine prostate cancer$350,381
ZIA · FY2022 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$116,794
ZIA · FY2022 · CA · contact PI
Mechanisms of pathogenesis in patient derived organoid models of prostate cancer$1,700,692
ZIA · FY2021 · CA · contact PI
Identifying genetic vulnerabilities in neuroendocrine prostate cancer$340,139
ZIA · FY2021 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$113,380
ZIA · FY2021 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$113,380
ZIA · FY2021 · CA · contact PI
Mechanisms of pathogenesis in patient derived organoid models of prostate cancer$1,177,606
ZIA · FY2020 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$392,536
ZIA · FY2020 · CA · contact PI
Identifying genetic vulnerabilities in neuroendocrine prostate cancer$196,267
ZIA · FY2020 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$196,267
ZIA · FY2020 · CA · contact PI
Mechanisms of pathogenesis in patient derived organoid models of prostate cancer$747,170
ZIA · FY2019 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$640,431
ZIA · FY2019 · CA · contact PI
Ras-mediated signals in human epithelial cell transformation and metastasis$320,216
ZIA · FY2019 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$213,477
ZIA · FY2019 · CA · contact PI
Identifying genetic vulnerabilities in neuroendocrine prostate cancer$106,739
ZIA · FY2019 · CA · contact PI
A Mitogen-induced G Protein-coupled Receptor$106,739
ZIA · FY2019 · CA · contact PI
Mechanisms of pathogenesis in patient derived organoid models of prostate cancer$764,220
ZIA · FY2018 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$655,046
ZIA · FY2018 · CA · contact PI
Ras-mediated signals in human epithelial cell transformation and metastasis$327,523
ZIA · FY2018 · CA · contact PI
Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility$304,881
ZIC · FY2018 · CA · contact PI
A Mitogen-induced G Protein-coupled Receptor$218,349
ZIA · FY2018 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$218,349
ZIA · FY2018 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$978,122
ZIA · FY2016 · CA · contact PI
Ras-mediated signals in human epithelial cell transformation and metastasis$586,874
ZIA · FY2016 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$195,624
ZIA · FY2016 · CA · contact PI
A Mitogen-induced G Protein-coupled Receptor$195,624
ZIA · FY2016 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$772,849
ZIA · FY2015 · CA · contact PI
Ras-mediated signals in human epithelial cell transformation and metastasis$463,709
ZIA · FY2015 · CA · contact PI
A Mitogen-induced G Protein-coupled Receptor$154,569
ZIA · FY2015 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$154,569
ZIA · FY2015 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$729,441
ZIA · FY2014 · CA · contact PI
Ras-mediated signals in human epithelial cell transformation and metastasis$437,665
ZIA · FY2014 · CA · contact PI
A Mitogen-induced G Protein-coupled Receptor$145,888
ZIA · FY2014 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$145,888
ZIA · FY2014 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$636,821
ZIA · FY2013 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$353,789
ZIA · FY2013 · CA · contact PI
Ras-mediated signals in human epithelial cell transformation and metastasis$283,032
ZIA · FY2013 · CA · contact PI
A Mitogen-induced G Protein-coupled Receptor$141,516
ZIA · FY2013 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$788,424
ZIA · FY2012 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$438,013
ZIA · FY2012 · CA · contact PI
Ras-mediated signals in human epithelial cell transformation and metastasis$350,410
ZIA · FY2012 · CA · contact PI
A Mitogen-induced G Protein-coupled Receptor$175,205
ZIA · FY2012 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$571,994
ZIA · FY2011 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$317,774
ZIA · FY2011 · CA · contact PI
Ras-mediated signals in human epithelial cell transformation and metastasis$254,220
ZIA · FY2011 · CA · contact PI
A Mitogen-induced G Protein-coupled Receptor$127,110
ZIA · FY2011 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$517,218
ZIA · FY2010 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$323,262
ZIA · FY2010 · CA · contact PI
Ras-mediated signals in human epithelial cell transformation and metastasis$258,609
ZIA · FY2010 · CA · contact PI
In Vivo MRI imaging of single metastatic cells$129,304
ZIA · FY2010 · CA · contact PI
A Mitogen-induced G Protein-coupled Receptor$64,653
ZIA · FY2010 · CA · contact PI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer$744,376
ZIA · FY2009 · CA · contact PI
Ras-mediated signals in human epithelial cell transformation and metastasis$297,751
ZIA · FY2009 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$148,875
ZIA · FY2009 · CA · contact PI
A Mitogen-induced G Protein-coupled Receptor$148,875
ZIA · FY2009 · CA · contact PI
In Vivo MRI imaging of single metastatic cells$148,875
ZIA · FY2009 · CA · contact PI
TMPRSS2-ERG chromosomal translocations and prostate cancer$91,314
Z01 · FY2008 · CA · contact PI